- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/705 - RécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire
Détention brevets de la classe C07K 14/705
Brevets de cette classe: 14744
Historique des publications depuis 10 ans
|
646
|
758
|
943
|
1061
|
1102
|
1294
|
1263
|
1203
|
1191
|
729
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19989 |
316 |
| The Trustees of the University of Pennsylvania | 4326 |
314 |
| The Board of Trustees of the Leland Stanford Junior University | 6433 |
207 |
| Memorial Sloan-Kettering Cancer Center | 1936 |
183 |
| Regeneron Pharmaceuticals, Inc. | 4296 |
181 |
| Board of Regents, The University of Texas System | 5821 |
167 |
| Immatics Biotechnologies GmbH | 1156 |
152 |
| Novartis AG | 10741 |
142 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2858 |
129 |
| The General Hospital Corporation | 4749 |
92 |
| City of Hope | 994 |
87 |
| Autolus Limited | 252 |
82 |
| Dana-Farber Cancer Institute, Inc. | 2574 |
79 |
| CRISPR Therapeutics AG | 366 |
78 |
| Alpine Immune Sciences, Inc. | 80 |
73 |
| Baylor College of Medicine | 952 |
73 |
| Juno Therapeutics, Inc. | 415 |
67 |
| Lentigen Technology, Inc. | 100 |
67 |
| The Johns Hopkins University | 5679 |
65 |
| Fred Hutchinson Cancer Center | 450 |
65 |
| Autres propriétaires | 12125 |